IQVIA leverages advanced technologies to enhance healthcare outcomes through its innovative solutions. Central to its offerings is the IQVIA AI Assistant, a generative AI interface that allows users to interact with products and solutions for rapid insights. The company emphasizes the importance of "Healthcare-grade AI™," which combines precision, speed, and scale with trust and reliability. This AI-driven approach is complemented by a robust analytics framework that includes the Analytics Research Accelerator, which enables teams to generate reliable insights from real-world data efficiently. IQVIA's extensive data assets, processing over 120 billion healthcare records annually, empower organizations to make informed decisions and optimize clinical development processes.

Additionally, IQVIA's technologies focus on orchestrating clinical trials and enhancing patient engagement. The company offers modular, interoperable technologies that streamline trial processes and improve site-sponsor relationships. Their Patient Engagement Suite and Digital Site Suite are designed to simplify the trial experience, enhance data quality, and improve overall clinical trial outcomes. By integrating advanced analytics and real-world evidence generation, IQVIA aims to transform clinical development, reduce risks, and accelerate the delivery of life-changing therapies to patients. This comprehensive approach positions IQVIA as a leader in the life sciences industry, recognized for its commitment to driving healthcare innovations globally.

United States

IQVIA applies data science to the continuous advancement of human science to make health care decisions more precise, relevant, and even creative.

IQVIA

Company Details